Xifaxan 550 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DR26F4Q9M
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $23,351
Award facts
- Contract value 100% obligated
- $23,350.70 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $23,350.70 firm fixed-price delivery order to Amerisourcebergen Drug Corp on July 22, 2026, for Xifaxan 550 mg tablets (60-count).
Place of performance is Conshohocken, PA. The order's ultimate completion date is July 23, 2026. No parent vehicle identifier appears in the source. Amerisourcebergen operates as a pharmaceutical wholesaler and medical distributor supplying the Department of Defense and federal healthcare systems without set-aside restrictions and holds no SBA certifications.
Quick answers
Who was awarded contract SPE2DR26F4Q9M?
SPE2DR26F4Q9M was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 22, 2026.
How much is contract SPE2DR26F4Q9M worth?
The government has obligated $23,351 on SPE2DR26F4Q9M.
Is contract SPE2DR26F4Q9M an order under another contract?
Yes. SPE2DR26F4Q9M is a delivery order under SPE2DR25D3012, an indefinite delivery contract.
Was contract SPE2DR26F4Q9M competed?
The extent of competition for SPE2DR26F4Q9M was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award